HOME   |    PDF   |   


Title

Line probe assay for isoniazid mono-resistant pulmonary tuberculosis at IGIMS, Patna, India

 

Authors

Reeta Kumari 1, Rakesh Kumar 1,*, Sweta Muni 1, Manish Shankar 2, Kumar Saurabh 1 & Arshad Ejazi 2

 

Affiliation

1Department of Microbiology, Indira Gandhi Institute of Medical Sciences (IGIMS), Patna, Bihar, India; 2Department of Pulmonary Medicine, Indira Gandhi Institute of Medical Sciences (IGIMS), Patna, Bihar, India; *Corresponding author

 

Email

Reeta Kumari - E-mail: reetakri2025@gmail.com
Rakesh Kumar - E-mail: rakesh.stdc@gmail.com
Sweta Muni - E-mail: drswetamuni@gmail.com
Manish Shankar - E-mail: drmnsh@gmail.com
Kumar Saurabh - E-mail: kr.saurabh14@gmail.com
Arshad Ejazi - E-mail: ejaziarshad@gmail.com
 

Article Type

Research Article

 

Date

Received October 1, 2026; Revised October 31, 2026; Accepted October 31, 2026, Published October 31, 2026

 

Abstract

Isoniazid mono-resistance is a common form of drug-resistant pulmonary tuberculosis and rapid detection is essential to improve treatment outcomes and limit disease transmission. Therefore, it is of interest to evaluate the performance of line probe assay for detecting isoniazid mono-resistance and associated genetic mutations in 81 rifampicin-sensitive pulmonary tuberculosis patients over 18 months, using culture-based drug susceptibility testing as the reference standard. Clinical specimens were analyzed by Ziehl-Neelsen staining, GeneXpert, Mycobacteria Growth Indicator Tube 960 culture, drug susceptibility testing and Line Probe Assay, with diagnostic performance assessed using sensitivity, specificity and chi-square analysis. Line Probe Assay showed rapid and reliable detection of isoniazid mono-resistance and its associated genetic mutations, facilitating earlier identification than conventional culture-based methods. Thus, data support the incorporation of line probe assay into routine diagnostic algorithms for timely initiation of appropriate therapy and improved management of drug-resistant pulmonary tuberculosis.

 

Keywords

Tuberculosis, isoniazid mono-resistance, line probe assay, MGIT 960, GENEXPERT, katG, inhA

 

Citation

Kumari et al. Bioinformation 22(10): 6390-6395 (2026)

 

Edited by

Vini Mehta

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.